---
title: "amfetamine - Attention deficit hyperactivity disorder"
sidebar: mydoc_sidebar
permalink: amfetamineattentiondeficithyperactivitydisorder3.html
toc: false 
---

{% include image.html file="amfetamineattentiondeficithyperactivitydisorder3.png" alt="amfetamineattentiondeficithyperactivitydisorder3" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000661 | amfetamine | Drug |
| UniProt:Q99870 | Vesicle monoamine transporter type 2 | Protein |
| GO:0098584 | presynaptic nerve terminal | CellularComponent |
| MESH:D004298 | dopamine | ChemicalSubstance |
| GO:0045202 | synapse | CellularComponent |
| MESH:D001289 | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Amfetamine | CONTRIBUTES TO | Vesicle Monoamine Transporter Type 2 |
| Vesicle Monoamine Transporter Type 2 | LOCATED IN | Presynaptic Nerve Terminal |
| Presynaptic Nerve Terminal | PRODUCES | Dopamine |
| Dopamine | LOCATED IN | Synapse |
| Synapse | TREATS | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00182#mechanism-of-action](https://go.drugbank.com/drugs/DB00182#mechanism-of-action){:target="_blank"}